Melatonina Pharma Nord (Melatonin)

Melatonin acts as an agonist at the MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. By binding these receptors, it signals the body that it is nighttime, helping to synchronize circadian rhythms and facilitate the transition to sleep.

The appropriate dose of melatonin is individualized. A prescriber determines the strength and frequency based on the patient’s age, the specific sleep disorder being treated, and any other relevant clinical factors.

Safety data for melatonin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk, and this decision must be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melatonin differs from traditional hypnotics because it works by mimicking a natural hormone rather than depressing the central nervous system. It is generally considered for short‑term or circadian‑related sleep disturbances, whereas benzodiazepines or non‑benzodiazepine hypnotics are used for broader insomnia indications.

The product should be stored at ambient temperature, below 25 °C, in its original packaging. Protect it from excess moisture, direct sunlight and extreme temperatures to maintain potency.

Melatonina Pharma Nord is taken orally, typically with a glass of water. It is usually taken shortly before the desired bedtime, following the dosage instructions provided by the prescribing clinician.

Serious but rare risks include severe allergic reactions, significant mood changes such as depression or irritability, and hormonal disturbances that could affect reproductive function. Patients should seek medical attention if they experience any of these symptoms.

Melatonin should be avoided in individuals with known hypersensitivity to melatonin, those taking certain anticoagulants or immunosuppressants without medical supervision, and patients with uncontrolled depression or seizure disorders unless specifically advised by a healthcare professional.